Notice of Award of a Single-Source Cooperative Agreement To Fund the Pan American Health Organization (PAHO): Building Capacity and Networks To Address Emerging Infectious Diseases in the Americas, 1579-1580 [2023-00384]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
EXPORT-IMPORT BANK
Sunshine Act Meetings
Notice of an Open Meeting of the
Board of Directors of the Export-Import
Bank of the United States.
TIME AND DATE: Thursday, January 19,
2023, at 9:30 a.m.
PLACE: The meeting will be held via
teleconference.
STATUS: The meeting will be open to
public observation.
MATTERS TO BE CONSIDERED:
1. OECD Local Cost Increase
2. Policy Proposal for EXIM Financing
5G Transactions
CONTACT PERSON FOR MORE INFORMATION:
Joyce B. Stone (202–257–4086).
Members of the public who wish to
attend the meeting may do so via
teleconference and must register using
the link below by noon Wednesday
January 18, 2023. After completing the
registration, individuals will receive a
confirmation email containing
information about joining the webinar.
https://teams.microsoft.com/
registration/
PAFTuZHHMk2Zb1GDkIVFJw,
pHLqbjVTrkuy_9KepKN6dQ,
MFtnLzltSEGI6EQECdI5iQ,
o8qJl3kYJk2L_ABN4wY_
ug,vZM4El7UYUeG_MAW1OfxbQ,
ty6uKl1vfUiw6R_zQ61RpA?mode=
read&tenantId=b953013c-c791-4d32996f-518390854527.
Joyce B. Stone,
Assistant Corporate Secretary.
[FR Doc. 2023–00482 Filed 1–9–23; 11:15 am]
BILLING CODE 6690–01–P
FEDERAL RESERVE SYSTEM
B. Federal Reserve Bank of Kansas City
(Jeffrey Imgarten, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
lotter on DSK11XQN23PROD with NOTICES1
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
VerDate Sep<11>2014
17:35 Jan 10, 2023
Jkt 259001
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than January 26, 2023.
A. Federal Reserve Bank of
Minneapolis (Stephanie Weber,
Assistant Vice President), 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291. Comments can also be sent
electronically to MA@mpls.frb.org:
1. The Gasterland Family GST Trust,
La Crosse, Wisconsin; Dirk R.
Gasterland, individually and as trustee,
Chaska, Minnesota; Jennifer
VandenBrink, individually and as
trustee, Chanhassen, Minnesota; Lloyd
Michael Gilbertson, Grand Rapids,
Minnesota; Olaf Gilbertson, Jordan,
Minnesota; Gretchen GasterlandGustafsson, Grace Gasterland, and a
certain minor child, all of St. Paul,
Minnesota; Natalie Gasterland, Chicago,
Illinois; Emma Gasterland-Gustafsson,
Brooklyn, New York; and Lilly
Gasterland-Gustafsson, New York, New
York; to join the Gasterland Control
Group, a group acting in concert, to
retain voting shares of Coulee
Bancshares, Inc., and thereby indirectly
retain voting shares of Coulee Bank,
both of La Crosse, Wisconsin.
1. Johannes Wilhelmus Antonius
Zuurbier, Amsterdam, Netherlands; to
acquire voting shares of Steinauer
Bancorp, and thereby indirectly acquire
voting shares of Bank of Steinauer, both
of Steinauer, Nebraska.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–00404 Filed 1–10–23; 8:45 am]
BILLING CODE 6210–01–P
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
1579
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Pan American Health Organization
(PAHO): Building Capacity and
Networks To Address Emerging
Infectious Diseases in the Americas
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $4,000,000,
with an expected total funding of
approximately $20,000,000 over a 5-year
period, to the Pan American Health
Organization (PAHO). The award will
continue support to PAHO in
developing and implementing
coordinated national and regional
public health programs in the Americas
that are consistent with the World
Health Organization’s International
Health Regulations (IHR) strategies and
the CDC global health priorities for
improving infectious disease
surveillance and response, building
public health infrastructure and
systems, sharing knowledge, tools and
other resources in support of applied
epidemiology, and developing improved
prevention and control strategies for
infectious disease, such as arboviruses,
coronaviruses, chikungunya, dengue,
yellow fever, Zika, HIV, poxviruses,
foodborne, antimicrobial resistant and
healthcare facility-acquired infectious
diseases.
DATES: The period for this award will be
09/03/2023 through 09/02/2028.
FOR FURTHER INFORMATION CONTACT:
Amanda (Amy) Pullman, National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention,
1600 Clifton Road NE, MS H24–11,
Atlanta, GA 30033, Telephone: 404–
718–5770 | TTY: (888) 232–6348, Email:
EPRB@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will assist Pan
American Health Organization (PAHO)
in the development and implementation
of coordinated plans and networks that
enable national governments and
regional authorities in the Americas to
implement IHR and better address
infectious diseases, particularly
emerging infections. Measurable
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
1580
Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
outcomes of the program will be in
alignment with CDC/NCEZID strategies
to strengthen and enhance the national
capacity of countries in the Americas to
detect, verify, assess, and respond to
outbreaks and other public health
emergencies of national and
international concern (PHEICs).
The PAHO is in a unique position to
conduct this work, as it was established
in 1902 by President Theodore
Roosevelt and more than three decades
before the United Nations and the
World Health Organization (WHO) as an
international public health agency that
works with the countries of the
Americas to improve the health and
quality of life of their populations.
PAHO is the Regional Office for the
Americas of the WHO as part of the
United Nations system. PAHO’s formal
treaty relationships with all the
ministries of health in the Americas
make it the only organization that can
carry out fully the proposed activities.
WHO and its Regional Offices
(including PAHO) are at the apex of
global public health organizations and
thus have an exclusive status as the
United States government’s key partners
for global public health. The
International Health Regulations (IHR
2005) is an international agreement that
requires WHO Member States to prevent
and respond to acute public health risks
that have the potential to cross borders
and threaten people worldwide.
lotter on DSK11XQN23PROD with NOTICES1
Summary of the Award
Recipient: Pan American Health
Organization (PAHO).
Purpose of the Award: The purpose of
this award is to continue support to
PAHO in developing and implementing
coordinated national and regional
public health programs in the Americas
that are consistent with the World
Health Organization’s International
Health Regulations (IHR) strategies and
the CDC global health priorities, and
better address infectious diseases,
particularly emerging infections.
Strategies and activities include
strengthening and enhancing the
national capacity of countries in the
Americas to detect, verify, assess, and
respond to outbreaks, including
arboviruses, coronaviruses,
chikungunya, dengue, yellow fever,
Zika, HIV, poxviruses, foodborne,
antimicrobial resistant and healthcare
facility-acquired infectious diseases,
and other public health emergencies of
national and international concern
(PHEICs).
Amount of Award: $4,000,000 in
Federal Fiscal Year (FFY) 2023 funds,
with a total estimated $20,000,000 for
VerDate Sep<11>2014
17:17 Jan 10, 2023
Jkt 259001
the 5-year period of performance,
subject to availability of funds.
Authority: This program is authorized
under sections 301 and 307 of the
Public Health Service Act, as amended
[42 U.S.C. 241 and 2421].
Period of Performance: 09/03/2023
through 09/02/2028.
Dated: January 6, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2023–00384 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–1294; Docket No. CDC–2022–
0143]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Maternal
Mortality Review Information
Application (MMRIA). MMRIA is a
standardized data collection system that
allows Maternal Mortality Review
Committees (MMRCs) to abstract
relevant data from a variety of sources,
document committee decisions, and
analyze data to better understand the
contributing factors and preventability
of pregnancy-related deaths in order to
develop recommendations for
prevention.
SUMMARY:
CDC must receive written
comments on or before March 13, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0143 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
DATES:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1579-1580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00384]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Pan American Health Organization (PAHO): Building Capacity and
Networks To Address Emerging Infectious Diseases in the Americas
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $4,000,000, with an expected total funding of
approximately $20,000,000 over a 5-year period, to the Pan American
Health Organization (PAHO). The award will continue support to PAHO in
developing and implementing coordinated national and regional public
health programs in the Americas that are consistent with the World
Health Organization's International Health Regulations (IHR) strategies
and the CDC global health priorities for improving infectious disease
surveillance and response, building public health infrastructure and
systems, sharing knowledge, tools and other resources in support of
applied epidemiology, and developing improved prevention and control
strategies for infectious disease, such as arboviruses, coronaviruses,
chikungunya, dengue, yellow fever, Zika, HIV, poxviruses, foodborne,
antimicrobial resistant and healthcare facility-acquired infectious
diseases.
DATES: The period for this award will be 09/03/2023 through 09/02/2028.
FOR FURTHER INFORMATION CONTACT: Amanda (Amy) Pullman, National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention, 1600 Clifton Road NE, MS H24-11,
Atlanta, GA 30033, Telephone: 404-718-5770 [verbar] TTY: (888) 232-
6348, Email: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will assist Pan
American Health Organization (PAHO) in the development and
implementation of coordinated plans and networks that enable national
governments and regional authorities in the Americas to implement IHR
and better address infectious diseases, particularly emerging
infections. Measurable
[[Page 1580]]
outcomes of the program will be in alignment with CDC/NCEZID strategies
to strengthen and enhance the national capacity of countries in the
Americas to detect, verify, assess, and respond to outbreaks and other
public health emergencies of national and international concern
(PHEICs).
The PAHO is in a unique position to conduct this work, as it was
established in 1902 by President Theodore Roosevelt and more than three
decades before the United Nations and the World Health Organization
(WHO) as an international public health agency that works with the
countries of the Americas to improve the health and quality of life of
their populations. PAHO is the Regional Office for the Americas of the
WHO as part of the United Nations system. PAHO's formal treaty
relationships with all the ministries of health in the Americas make it
the only organization that can carry out fully the proposed activities.
WHO and its Regional Offices (including PAHO) are at the apex of global
public health organizations and thus have an exclusive status as the
United States government's key partners for global public health. The
International Health Regulations (IHR 2005) is an international
agreement that requires WHO Member States to prevent and respond to
acute public health risks that have the potential to cross borders and
threaten people worldwide.
Summary of the Award
Recipient: Pan American Health Organization (PAHO).
Purpose of the Award: The purpose of this award is to continue
support to PAHO in developing and implementing coordinated national and
regional public health programs in the Americas that are consistent
with the World Health Organization's International Health Regulations
(IHR) strategies and the CDC global health priorities, and better
address infectious diseases, particularly emerging infections.
Strategies and activities include strengthening and enhancing the
national capacity of countries in the Americas to detect, verify,
assess, and respond to outbreaks, including arboviruses, coronaviruses,
chikungunya, dengue, yellow fever, Zika, HIV, poxviruses, foodborne,
antimicrobial resistant and healthcare facility-acquired infectious
diseases, and other public health emergencies of national and
international concern (PHEICs).
Amount of Award: $4,000,000 in Federal Fiscal Year (FFY) 2023
funds, with a total estimated $20,000,000 for the 5-year period of
performance, subject to availability of funds.
Authority: This program is authorized under sections 301 and 307 of
the Public Health Service Act, as amended [42 U.S.C. 241 and 2421].
Period of Performance: 09/03/2023 through 09/02/2028.
Dated: January 6, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023-00384 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P
